Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indomethacin for Pregnancy Prolongation in PPROM
NCT00466128Phase 2Unknown
- Sponsor
- Thomas Jefferson University
- Start
- Apr 2007
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of indomethacin in preterm premature rupture of membranes (pPROM), sponsored by Thomas Jefferson University. Primary endpoint: Prolongation of pregnancy for 48 hours. Status: unknown.
02
Drugs
indomethacin
03
Conditions
preterm premature rupture of membranes (pPROM)
Beyond the preview
Go deeper on NCT00466128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00466128.